Observed arrival · 2026-10-17
BreathDX puts a cancer-screening claim in a working device
AATG presents a handheld breath sampler, compact analyzer and AI risk report as a point-of-care cancer-screening system.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- People evaluating point-of-care breath diagnostics
- Worth noticing
- The page describes a 300 mL multi-breath sample and says the prototype captures real breath data.
Field notes
The page lays out a sequence from a 300 mL multi-breath sample to a compact analyzer and an AI risk report, with lung and breast cancer named as targets. It labels the BreathDX-C hardware a working prototype and links to a live demo, while also referring to a detection core called r-Guard. The page's claims about screening and turnaround time are presented by AATG; the supplied extract contains no clinical validation results.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
◎NicheUnusually specific use
One card from the complete issue